Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity
- 14 August 2009
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 386 (1), 16-20
- https://doi.org/10.1016/j.bbrc.2009.05.106
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple SclerosisThe Journal of Immunology, 2009
- Important role for AMPKαl in limiting skeletal muscle cell hypertrophyThe FASEB Journal, 2009
- Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissueThe EMBO Journal, 2008
- AMP‐activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and functionEuropean Journal of Immunology, 2008
- Control of AMPK-related kinases by USP9X and atypical Lys29/Lys33-linked polyubiquitin chainsBiochemical Journal, 2008
- The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe DiseaseJournal of Neurochemistry, 2008
- Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytesThe Journal of Experimental Medicine, 2006
- Effects of α‐AMPK knockout on exercise‐induced gene activation in mouse skeletal muscleThe FASEB Journal, 2005
- IMMUNOLOGY OF MULTIPLE SCLEROSISAnnual Review of Immunology, 2005
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995